Works matching DE "UNITED States. Food %26 Drug Administration"
Results: 5000
Adverse event signal analysis of remimazolam using the FDA adverse event reporting system database.
- Published in:
- Acta Anaesthesiologica Scandinavica, 2025, v. 69, n. 3, p. 1, doi. 10.1111/aas.14588
- By:
- Publication type:
- Article
MDMA-Assisted Therapy for Post-Traumatic Stress Disorder: Regulatory Challenges and a Path Forward: MDMA-Assisted Therapy for Post-Traumatic Stress Disorder: B. Singh.
- Published in:
- CNS Drugs, 2025, v. 39, n. 4, p. 339, doi. 10.1007/s40263-025-01162-y
- By:
- Publication type:
- Article
Combating opioid misuse in Nigeria: A comprehensive strategy for public health and social stability.
- Published in:
- Addiction, 2025, v. 120, n. 2, p. 385, doi. 10.1111/add.16710
- By:
- Publication type:
- Article
GLP‐1R agonist medications for addiction treatment.
- Published in:
- Addiction, 2025, v. 120, n. 2, p. 198, doi. 10.1111/add.16626
- By:
- Publication type:
- Article
Artificial intelligence‐based drug repurposing with electronic health record clinical corroboration: A case for ketamine as a potential treatment for amphetamine‐type stimulant use disorder.
- Published in:
- Addiction, 2025, v. 120, n. 4, p. 732, doi. 10.1111/add.16715
- By:
- Publication type:
- Article
Published ASPIRE data show noninferior stone-free rate with SURE vs URS: Significantly better stone clearance also observed with CVAC device.
- Published in:
- Urology Times, 2025, v. 53, n. 2, p. 30
- By:
- Publication type:
- Article
UroPipeline.
- Published in:
- Urology Times, 2025, v. 53, n. 2, p. 24
- By:
- Publication type:
- Article
Statins combined with niacin reduce the risk of peripheral neuropathy.
- Published in:
- International Journal of Functional Nutrition, 2020, v. 1, n. 1, p. N.PAG, doi. 10.3892/ijfn.2020.3
- By:
- Publication type:
- Article
Recent and anticipated novel drug approvals (4Q 2024 through 3Q 2025).
- Published in:
- American Journal of Health-System Pharmacy, 2025, v. 82, n. 6, p. 291, doi. 10.1093/ajhp/zxae352
- By:
- Publication type:
- Article
Considerations for developing a health-system 503B outsourcing strategy.
- Published in:
- American Journal of Health-System Pharmacy, 2025, v. 82, n. 6, p. 350, doi. 10.1093/ajhp/zxae271
- By:
- Publication type:
- Article
FDA Approves Generic Liraglutide to Address GLP-1 Drug Shortage.
- Published in:
- JAMA: Journal of the American Medical Association, 2025, v. 333, n. 9, p. 746, doi. 10.1001/jama.2024.28813
- By:
- Publication type:
- Article
Treatment of Attention-Deficit/Hyperactivity Disorder With Stimulants: Reducing Harms.
- Published in:
- Journal of Psychosocial Nursing & Mental Health Services, 2025, v. 63, n. 3, p. 7, doi. 10.3928/02793695-20250212-02
- By:
- Publication type:
- Article
FDA-Approved Drugs to Treat ADHD.
- Published in:
- Journal of Psychosocial Nursing & Mental Health Services, 2025, v. 63, n. 3, p. 5, doi. 10.3928/02793695-20250128-79
- Publication type:
- Article
Should Xenotransplantation Surgeries Be Authorized Under the Food and Drug Administration's Expanded Access Pathway?
- Published in:
- AMA Journal of Ethics, 2025, v. 27, n. 3, p. 197, doi. 10.1001/amajethics.2025.197
- By:
- Publication type:
- Article
Effect of a Single Dose of Metoclopramide on Gastric Volume in Fasting Diabetic Patients Measured using Ultrasonography: A Randomised Controlled Trial.
- Published in:
- Journal of Clinical & Diagnostic Research, 2025, v. 19, n. 2, p. 57, doi. 10.7860/JCDR/2025/76690.20681
- By:
- Publication type:
- Article
Investigating Drug-Induced Thyroid Dysfunction Adverse Events Associated With Non-Selective RET Multi-Kinase Inhibitors: A Pharmacovigilance Analysis Utilizing FDA Adverse Event Reporting System Data.
- Published in:
- Clinical Epidemiology, 2025, v. 17, p. 87, doi. 10.2147/CLEP.S494215
- By:
- Publication type:
- Article
Sotorasib Combo Bests Chemo Leading to Approval in KRAS G12C+ CRC.
- Published in:
- Oncology (08909091), 2025, v. 39, n. 2, p. 85
- By:
- Publication type:
- Article
CDC: Heplisav-B Joins Recommended HBV Vaccine Options for Pregnant Patients.
- Published in:
- Healio Gastroenterology, 2025, v. 11, n. 2, p. 24
- By:
- Publication type:
- Article
FDA Fast Tracks Lipocine's Oral Androgen Receptor Agonist for Sarcopenia in Cirrhosis.
- Published in:
- Healio Gastroenterology, 2025, v. 11, n. 2, p. 16
- Publication type:
- Article
FDA Approves Combination Regimen for Metastatic Colorectal Cancer.
- Published in:
- Healio Gastroenterology, 2025, v. 11, n. 2, p. 16
- By:
- Publication type:
- Article
Alfapump Implant Gains FDA Premarket Approval for Recurrent, Refractory Cirrhotic Ascites.
- Published in:
- Healio Gastroenterology, 2025, v. 11, n. 2, p. 15
- Publication type:
- Article
Cour Pharmaceuticals Snags Orphan Drug Designation for CNP-104 for the Treatment of PBC.
- Published in:
- Healio Gastroenterology, 2025, v. 11, n. 2, p. 15
- Publication type:
- Article
FDA Approves Ionis' Tryngolza as First Treatment for Familial Chylomicronemia Syndrome.
- Published in:
- Healio Gastroenterology, 2025, v. 11, n. 2, p. 14
- Publication type:
- Article
FDA Approves Yesintek, Sixth Stelara Biosimilar; Launch Slated for February.
- Published in:
- Healio Gastroenterology, 2025, v. 11, n. 1, p. 24
- Publication type:
- Article
FDA: Ocaliva Still Linked to 'Serious Liver Injury' in PBC, Even Without Cirrhosis.
- Published in:
- Healio Gastroenterology, 2025, v. 11, n. 1, p. 11
- Publication type:
- Article
Assessment of disposal practices for unused medication: a multi-center cross-sectional study of patients visiting public health facilities in northwest Ethiopia.
- Published in:
- Journal of Public Health: From Theory to Practice (2198-1833), 2024, v. 32, n. 8, p. 1443, doi. 10.1007/s10389-023-01920-6
- By:
- Publication type:
- Article
The Benefits of Sustaining High Factor VIII Levels in People With Hemophilia A.
- Published in:
- American Journal of Managed Care, 2025, p. S15, doi. 10.37765/ajmc.2025.89703
- By:
- Publication type:
- Article
FDA approves first treatment for cerebrotendinous xanthomatosis, a rare lipid storage disease.
- Published in:
- Rhode Island Medical Journal, 2025, v. 108, n. 3, p. 56
- Publication type:
- Article
FDA approves first rapid-acting insulin biosimilar product for treatment of diabetes.
- Published in:
- Rhode Island Medical Journal, 2025, v. 108, n. 3, p. 55
- Publication type:
- Article
FDA approves novel non-opioid treatment for moderate to severe acute pain.
- Published in:
- Rhode Island Medical Journal, 2025, v. 108, n. 3, p. 55
- Publication type:
- Article
INDUSTRY PIPELINE.
- Published in:
- Ocular Surgery News, 2025, v. 43, n. 4, p. 26
- Publication type:
- Article
FDA's "Healthy" Food Rule Updated for First Time in 30 Years.
- Published in:
- JAMA: Journal of the American Medical Association, 2025, v. 333, n. 8, p. 656, doi. 10.1001/jama.2024.28056
- By:
- Publication type:
- Article
FDA Approves Tirzepatide as First Drug for Obstructive Sleep Apnea.
- Published in:
- JAMA: Journal of the American Medical Association, 2025, v. 333, n. 8, p. 656, doi. 10.1001/jama.2024.28055
- By:
- Publication type:
- Article
Investigating Pharmaceutical Nanotechnology: Opportunities and Challenges.
- Published in:
- Pharmaceutical & Biomedical Research, 2024, v. 10, n. 4, p. 275, doi. 10.32598/PBR.10.4.369.3
- By:
- Publication type:
- Article
FDA Regulation of Menstrual Devices: Increased Innovation, Decreased Oversight, and Shifting Problems.
- Published in:
- Women's Reproductive Health, 2025, v. 12, n. 1, p. 59, doi. 10.1080/23293691.2024.2380443
- By:
- Publication type:
- Article
Safety analysis of romiplostim, eltrombopag, and avatrombopag post-market approval: a pharmacovigilance study based on the FDA Adverse Event Reporting System.
- Published in:
- BMC Pharmacology & Toxicology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s40360-025-00873-8
- By:
- Publication type:
- Article
Diabetic Ketoacidosis and the Use of New Hypoglycemic Groups: Real-World Evidence Utilizing the Food and Drug Administration Adverse Event Reporting System.
- Published in:
- Pharmaceuticals (14248247), 2025, v. 18, n. 2, p. 214, doi. 10.3390/ph18020214
- By:
- Publication type:
- Article
New Serious Safety Warnings for Targeted Anticancer Agents After Their Initial FDA Approval.
- Published in:
- Cancers, 2025, v. 17, n. 4, p. 584, doi. 10.3390/cancers17040584
- By:
- Publication type:
- Article
Therapeutic Evaluation and Utilization Analysis of Mental Health Prescription Digital Therapeutics Within the Current Regulatory Landscape.
- Published in:
- Pharmacy, 2025, v. 13, n. 1, p. 19, doi. 10.3390/pharmacy13010019
- By:
- Publication type:
- Article
FDA-Approved Antibacterials and Echinocandins.
- Published in:
- Antibiotics (2079-6382), 2025, v. 14, n. 2, p. 166, doi. 10.3390/antibiotics14020166
- By:
- Publication type:
- Article
Bridging the Gap in FDA Approval for Pediatric Neuromodulation Devices.
- Published in:
- Children, 2025, v. 12, n. 2, p. 148, doi. 10.3390/children12020148
- By:
- Publication type:
- Article
Exploring the Impact of Serious Games for Cognitive Functions through the Humphrey Fellowship Programme.
- Published in:
- Malaysian Journal of Medical Sciences, 2018, v. 25, n. 3, p. 1, doi. 10.21315/mjms2018.25.3.1
- By:
- Publication type:
- Article
Energy Drink Adverse Effects: What Is Being Done to Protect Public Health?
- Published in:
- 2018
- By:
- Publication type:
- Editorial
COCHLEAR IMPLANTS FOR CHILDREN WITH UNILATERAL HEARING LOSS: DEBUNKING THE MYTHS.
- Published in:
- Volta Review, 2023, v. 123, n. 1, p. 45, doi. 10.17955/tvr.123.1.symp4
- By:
- Publication type:
- Article
Treatment of Medication-Related Osteonecrosis of the Jaw Around the Dental Implant With a Once-Weekly Teriparatide: A Case Report and Literature Review.
- Published in:
- Journal of Oral Implantology, 2019, v. 45, n. 5, p. 403, doi. 10.1563/aaid-joi-D-19-00040
- By:
- Publication type:
- Article
Blade-Form Dental Implants: FDA Reclassification as a Class II Dental Implant Device.
- Published in:
- 2013
- By:
- Publication type:
- Editorial
Food and Drug Administration: Reclassification of Blade Form Dental Implants.
- Published in:
- Journal of Oral Implantology, 2013, v. 39, n. 5, p. 523, doi. 10.1563/AAID-JOI-D-13-00230
- By:
- Publication type:
- Article
Correction: Lotilaner ophthalmic solution 0.25% in Demodex blepharitis: a profile of its use.
- Published in:
- 2025
- By:
- Publication type:
- Correction Notice
New therapies for primary biliary cholangitis usher in a personalised approach to treatment.
- Published in:
- Drugs & Therapy Perspectives, 2025, v. 41, n. 1, p. 28, doi. 10.1007/s40267-024-01129-x
- By:
- Publication type:
- Article
Lotilaner ophthalmic solution 0.25% in Demodex blepharitis: a profile of its use.
- Published in:
- Drugs & Therapy Perspectives, 2024, v. 40, n. 11, p. 444, doi. 10.1007/s40267-024-01111-7
- By:
- Publication type:
- Article